Table 3. Correlations between AUCMTX and the other analysed variables.
Variables | Subgroups | No. | AUCMTX (mean±s.d. μmol h l−1) | P |
---|---|---|---|---|
Age | ⩽60 years | 30 | 846±562 | |
>60 years | 15 | 502±359 | 0.02 | |
Sex | Females | 16 | 540±398 | |
Males | 29 | 837±562 | 0.08 | |
PS | 0–1 | 19 | 927±614 | |
2–4 | 26 | 589±405 | 0.08 | |
Anticonvulsants | No | 14 | 1028±662 | |
Yes | 31 | 598±394 | 0.04 | |
IRMTX (mg m−2 h−1) | ⩽800 | 33 | 635±564 | |
>800 | 12 | 996±274 | 0.003 | |
DIMTX (mg m−2 week−1) | ⩽1000 | 33 | 559±392 | |
>1000 | 12 | 1206±567 | 0.0003 | |
CLcrea (ml min−1) | ⩽85 | 12 | 604±434 | |
>85 | 33 | 778±553 | 0.35 | |
Chemotherapy regimen | HD-MTX | 10 | 857±658 | |
MATILde | 11 | 1043±240 | ||
MTX+AraC | 24 | 536±491 | 0.008 |
PS=performance status according to the ECOG score.